Medicine
fromTNW | Health-Tech
18 hours agoHexemBio raises $10.4M for a stem cell rejuvenation therapy
HexemBio develops a blood stem cell rejuvenation therapy using a recreated embryonic environment, targeting bone marrow transplants for blood cancers.